DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ddavp Injection (Desmopressin Acetate) - Published Studies

 
 



Published Studies Related to Ddavp Injection (Desmopressin)

Well-designed clinical trials related to Ddavp Injection (Desmopressin)

Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors. [2012]

Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials. [2011.09.07]

Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. [2011.06]

Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. [2011.05]

Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effects. [2011.03]

Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin. [2011.03]

Randomized comparison of long-term desmopressin and alarm treatment for bedwetting. [2011.02]

Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. [2011.01]

Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. [2011.01]

Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. [2010.12]

An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis. [2010.08]

Effects of desmopressin on the sleep of children suffering from enuresis. [2010.07]

Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. [2010.01]

Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. [2010]

An Open Randomized Controlled Trial of Desmopressin, and Pulse Dexamethasone as Adjunctive Therapy in Patients with Pulmonary Involvement Associated with Severe Leptospirosis. [2009.09.02]

Clinical study shows improved absorption of desmopressin with novel formulation. [2009.07]

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. [2009.04]

Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome. [2009]

Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. [2008.11]

Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome. [2008.08.22]

Desmopressin increases IGF-binding protein-1 in humans. [2008.04]

Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. [2008.02]

The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study. [2007.04]

The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. [2007.02]

Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. [2006.10]

Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers. [2006.04]

The effect of desmopressin, a vasopressin analog, on endurance performance during a prolonged run in simulated heat conditions. [2006.04]

A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. [2006.03]

A bioequivalence study of two oral desmopressin tablet formulations. [2006]

Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial. [2005.09]

Anti-diuretic for operational aircrew: effects of desmopressin on urine flow, cognition, and sleepiness. [2005.08]

The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. [2005.04]

Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide. [2005.03]

Comparing alarms, desmopressin, and combined treatment in Chinese enuretic children. [2005.02]

The role of urine osmolality and ions in the pathogenesis of primary enuresis nocturna and in the prediction of responses to desmopressin and conditioning therapies. [2005]

Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. [2004.08]

Desmopressin has an influence on the arousability of children with primary nocturnal enuresis. [2004.06]

Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis. [2004.03]

Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. [2004.03]

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. [2003.12.15]

Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. [2003.11]

A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. [2003.11]

Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. [2003.10]

GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. [2003.03]

Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. [2003.01]

DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study. [2002.11]

The influence of lithium on the antidiuretic effect of desmopressin. [2002.09]

Comparison between nasal and intravenous desmopressin for the treatment of aminosalicylic acid-induced platelet dysfunction. [2002.09]

Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. [2002.06]

Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time. [2002.04]

Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis? [2002.03]

Desmopressin usage in elective cardiac surgery. [2001.12]

Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis. [2001.12]

The effect of desmopressin on short-term memory in children with primary nocturnal enuresis. [2001.12]

The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. [2001.12]

The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. [2001.11]

A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement. [2001.10]

Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. [2001.08]

A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution. [2001.05]

An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colic. [2001.03]

Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. [2000.12]

Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome. [2000.06]

The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndrome. [2000.03]

Effect kinetics of desmopressin-induced platelet retention in healthy volunteers treated with aspirin or placebo. [2000.01]

Desmopressin resistant enuresis: pathogenetic and therapeutic considerations. [1999.12]

ACTH and cortisol release following intravenous desmopressin: a dose-response study. [1999.11]

Indirect-response modeling of desmopressin at different levels of hydration. [1999.10]

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. [1999.07.10]

Desmopressin in the treatment of nocturnal polyuria in the male. [1999.07]

Changes in gastrointestinal motility influence the absorption of desmopressin. [1999.06]

Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity. [1999.06]

Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. [1999.04]

[Treatment of isolated nocturnal enuresis: alarm or desmopressin?] [1999.03]

A controlled trial of desmopressin and behavioral therapy for nocturnal enuresis. [1998.11]

Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. [1998.11]

Administration of desmopressin in brain-dead donors and renal function in kidney recipients. [1998.10.10]

The duration of antidiuretic response of two desmopressin nasal sprays. [1998.09]

Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children. [1998.04]

A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays. [1998.03]

Desmopressin and low-dose ACTH test in rheumatoid arthritis. [1998.03]

The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. [1998.02.15]

Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. [1998.02]

Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. [1998.01.15]

Desmopressin for nocturnal enuresis: urinary osmolality and response. [1997.09]

Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. [1997.09]

A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double-blinded study. [1997.08]

Long-term treatment of nocturnal enuresis with desmopressin intranasal spray. [1997.08]

Effects of ovine corticotropin-releasing hormone injection and desmopressin coadministration on galanin and adrenocorticotropin plasma levels in normal women. [1997.02]

Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. Dutch Enuresis Study Group. [1997.02]

Desmopressin and imipramine in the management of nocturnal enuresis: a multicentre study. [1997.01]

A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome. [1997.01]

Bioavailability and pharmacokinetics of desmopressin in elderly men. [1997]

Combination therapy for nocturnal enuresis with desmopressin and an alarm device. [1997]

Desmopressin tablet treatment: factors influencing gastrointestinal absorption. [1997]

Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. [1997]

The role of DDAVP (desmopressin) in orthognathic surgery. [1996.11]

Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa. [1996.10]

The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. [1996.10]

Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. [1996.07]

Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. [1995.10]

Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. [1995.10]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017